Advertisement

Current Atherosclerosis Reports

, Volume 9, Issue 4, pp 249–251 | Cite as

The role of myeloperoxidase in HDL oxidation and atherogenesis

  • Jay W. HeineckeEmail author
Invited Commentary

Keywords

HOCl Arterioscler Thromb Vasc Biol Reverse Cholesterol Transport Hypochlorous Acid Cellular Cholesterol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Oram JF, Yokoyama S: Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J Lipid Res 1996, 37:2473–2491.PubMedGoogle Scholar
  2. 2.
    Rothblat GH, de la Llera-Moya M, Atger V, et al.: Cell cholesterol efflux: integration of old and new observations provides new insights. J Lipid Res 1999, 40:781–796.PubMedGoogle Scholar
  3. 3.
    Kennedy MA, Barrera GC, Nakamura K, et al.: ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab 2005, 1:121–131.PubMedCrossRefGoogle Scholar
  4. 4.
    Wang N, Lan D, Chen W, et al.: ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci U S A 2004, 101:9774–9779.PubMedCrossRefGoogle Scholar
  5. 5.
    Bowry VW, Stanley KK, Stocker R: High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc Natl Acad Sci U S A 1992, 89:10316–10320.PubMedCrossRefGoogle Scholar
  6. 6.
    Barter PJ, Nicholls S, Rye KA, et al.: Antiinflammatory properties of HDL. Circ Res 2004, 95:764–772.PubMedCrossRefGoogle Scholar
  7. 7.
    Garner B, Waldeck AR, Witting PK, et al.: Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII. J Biol Chem 1998, 273:6088–6095.PubMedCrossRefGoogle Scholar
  8. 8.
    Christison J, Karjalainen A, Brauman J, et al.: Rapid reduction and removal of HDL-but not LDL-associated cholesteryl ester hydroperoxides by rat liver perfused in situ. Biochem J 1996, 314(Pt 3):739–742.PubMedGoogle Scholar
  9. 9.
    Shao B, Oda MN, Oram JF, Heinecke JW: Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein. Curr Opin Cardiol 2006, 21:322–328.PubMedCrossRefGoogle Scholar
  10. 10.
    Carr AC, McCall MR, Frei B: Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection. Arterioscler Thromb Vasc Biol 2000, 20:1716–1723.PubMedGoogle Scholar
  11. 11.
    Daugherty A, Dunn JL, Rateri DL, Heinecke JW: Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 1994, 94:437–444.PubMedGoogle Scholar
  12. 12.
    Hazell LJ, Arnold L, Flowers D, et al.: Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest 1996, 97:1535–1544.PubMedCrossRefGoogle Scholar
  13. 13.
    Berliner JA, Heinecke JW: The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996, 20:707–727.PubMedCrossRefGoogle Scholar
  14. 14.
    Gaut JP, Byun J, Tran HD, et al.: Myeloperoxidase produces nitrating oxidants in vivo. J Clin Invest 2002, 109:1311–1319.PubMedCrossRefGoogle Scholar
  15. 15.
    Heinecke JW, Hsu FF, Crowley JR, et al.: Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry: sensitive and quantitative assays for oxidized amino acids in proteins and tissues. Meth Enzym 1999, 300:124–144.PubMedGoogle Scholar
  16. 16.
    Hazen SL, Heinecke JW: 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest 1997, 99:2075–2081.PubMedGoogle Scholar
  17. 17.
    Heinecke JW, Li W, Daehnke HL, Goldstein JA: Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J Biol Chem 1993, 268:4069–4077.PubMedGoogle Scholar
  18. 18.
    Leeuwenburgh C, Rasmussen JE, Hsu FF, et al.: Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J Biol Chem 1997, 272:3520–3526.PubMedCrossRefGoogle Scholar
  19. 19.
    Sugiyama S, Okada Y, Sukhova GK, et al.: Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 2001, 158:879–891.PubMedGoogle Scholar
  20. 20.
    McMillen TS, Heinecke JW, LeBoeuf RC: Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice. Circulation 2005, 111:2798–2804.PubMedCrossRefGoogle Scholar
  21. 21.
    Bergt C, Pennathur S, Fu X, et al.: The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc Natl Acad Sci U S A 2004, 101:13032–13037.PubMedCrossRefGoogle Scholar
  22. 22.
    Pennathur S, Bergt C, Shao B, et al.: Human a therosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species. J Biol Chem 2004, 279:42977–42983.PubMedCrossRefGoogle Scholar
  23. 23.
    Zheng L, Nukuna B, Brennan ML, et al.: Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 2004, 114:529–541.PubMedCrossRefGoogle Scholar
  24. 24.
    Shao B, Bergt C, Fu X, et al.: Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport. J Biol Chem 2005, 280:5983–5993.PubMedCrossRefGoogle Scholar
  25. 25.
    Curtiss LK, Valenta DT, Hime NJ, Rye KA: What is so special about apolipoprotein AI in reverse cholesterol transport? Arterioscler Thromb Vasc Biol 2006, 26:12–19.PubMedCrossRefGoogle Scholar
  26. 26.
    Bergt C, Fu X, Huq NP, et al.: Lysine residues direct the chlorination of tyrosines in YXXK motifs of apolipoprotein A-I when hypochlorous acid oxidizes high density lipoprotein. J Biol Chem 2004, 279:7856–7866.PubMedCrossRefGoogle Scholar
  27. 27.
    Shao B, Oda MN, Bergt C, et al.: Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I. J Biol Chem 2006, 281:9001–9004.PubMedCrossRefGoogle Scholar
  28. 28.
    Gaut JP, Yeh GC, Tran HD, et al.: Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc Natl Acad Sci U S A 2001, 98:11961–11966.PubMedCrossRefGoogle Scholar

Copyright information

© Current Medicine Group LLC 2007

Authors and Affiliations

  1. 1.Division of Metabolism, Endocrinology and NutritionUniversity of WashingtonSeattleUSA

Personalised recommendations